Recent studies have provided evidence that the neuroprotective effects of mTOR on stroke may be due to its ability to increase PSD95 and GAP-43 protein levels or promote neuronal structural stability in peri-infarct regions [77, 78]. The gene discussed is GAP43; the disease is stroke disorder.